Cargando…
Bone targeted therapies for the prevention of skeletal morbidity in men with prostate cancer
Men with prostate cancer suffer substantially from bone-related complications. Androgen deprivation therapy itself is a cause of loss of bone mineral density and is associated with an increased incidence of osteoporotic fractures. In advanced disease, bone is by far the most common site of metastasi...
Autor principal: | Saylor, Philip J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4023357/ https://www.ncbi.nlm.nih.gov/pubmed/24435057 http://dx.doi.org/10.4103/1008-682X.122591 |
Ejemplares similares
-
Bone-targeted therapies to reduce skeletal morbidity in prostate cancer
por: Dorff, Tanya B, et al.
Publicado: (2018) -
Testosterone therapy in men with prostate cancer: literature review, clinical experience, and recommendations
por: Morgentaler, Abraham, et al.
Publicado: (2015) -
Prostate Cancer Survivorship: Prevention and Treatment of the Adverse Effects of Androgen Deprivation Therapy
por: Saylor, Philip J., et al.
Publicado: (2009) -
Whole-body MRI: detecting bone metastases from prostate cancer
por: Nakanishi, Katsuyuki, et al.
Publicado: (2021) -
Multiple therapeutic and preventive effects of 3,3′-diindolylmethane on cancers including prostate cancer and high grade prostatic intraepithelial neoplasia
por: Zhang, William Weiben, et al.
Publicado: (2014)